ABIVAX SA (2X1.DE) Stock Income Statement
FRA:2X1 • FR0012333284
Current stock price
96.5 EUR
+0.4 (+0.42%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | 110.00K | 0.00 | |||
| Gross Profit | N/A | N/A | N/A | -110.00K | 0.00 | |||
| Operating Expenses | 246.06M | 172.98M | 127.38M | 51.09M | 42.56M | |||
| Research and Development | 177.76M | 146.53M | 103.18M | 48.30M | N/A | |||
| Selling, General, and Administrative Expenses | 72.86M | 38.90M | 28.82M | 7.49M | 6.37M | |||
| Operating Income | -246.06M | -172.98M | -127.38M | -51.20M | -42.56M | |||
| Interest Income/Expense | -49.86M | -1.51M | -15.82M | 3.87M | -436.00K | |||
| Other Income/Expense | -34.33M | -1.75M | -4.54M | 224.00K | -2.69M | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | -13.63M | 125.00K | |||
| Income Before Taxes | -330.25M | -176.24M | -147.74M | -60.74M | -45.56M | |||
| Income Tax | 5.85M | 0.00 | 0.00 | 0.00 | -4.20M | |||
| Net Income | -336.10M | -176.24M | -147.74M | -60.74M | -41.36M | |||
| EBITDA | -245.35M | -171.88M | -126.67M | -50.72M | -42.40M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.83 | -2.80 | -3.43 | -3.18 | -2.47 | |||
| Statistics | ||||||||
All data in EUR